Search Results 141-150 of 13187 for Tyrosine

  1. Hematology - Clinical trials

    This study will also allow participants who are currently progressing on a Bruton tyrosine kinase inhibitor (BTKi) and requiring salvage therapy as assessed ...

  2. Clinical trials - Oncology (Medical)

    Patients with ALK aberrant tumors (ALK tyrosine kinase mutation or ALK amplification) will be non-randomly assigned to receive crizotinib added to current COG ...

  3. Hematology - Clinical trials

    This study will also allow participants who are currently progressing on a Bruton tyrosine kinase inhibitor (BTKi) and requiring salvage therapy as assessed ...

  4. Cysteamine (oral route) - Side effects & dosage - Mayo Clinic

    Cysteamine is used to prevent damage that may be caused by the buildup of cystine crystals in organs such as the kidneys (nephropathic cystinosis). Cystinosis ...

  5. Clinical trials - Oncology (Medical)

    This study will also allow participants who are currently progressing on a Bruton tyrosine kinase inhibitor (BTKi) and requiring salvage therapy as assessed ...

  6. A Study To Evaluate The Combination Of Binimetinib And Palbociclib In Treating Patients With KRAS And NRAS Mutant Metastatic Or Unresectable Colorectal Cancer - Mayo Clinic

    ... tyrosine kinase inhibitor therapy. Note: Re-registration must occur ≤ 28 ... tyrosine kinase inhibitor. Participating Mayo Clinic locations. Study ...

  7. Hematology - Clinical trials

    This study will also allow participants who are currently progressing on a Bruton tyrosine kinase inhibitor (BTKi) and requiring salvage therapy as assessed ...

  8. Clinical trials - Oncology (Medical)

    Patients with ALK aberrant tumors (ALK tyrosine kinase mutation or ALK amplification) will be non-randomly assigned to receive crizotinib added to current COG ...

  9. Clinical trials - Oncology (Medical)

    This study will also allow participants who are currently progressing on a Bruton tyrosine kinase inhibitor (BTKi) and requiring salvage therapy as assessed ...

  10. Publications - Yul W. Yang, M.D., Ph.D. - Mayo Clinic

    ... tyrosine kinase inhibitor acneiform eruptions. J Am Acad Dermatol 2021 Mar; 84 (3):840-841 Epub 2020 Oct 08. View PubMed; Yang YW, Lehrer MD, Mangold AR ...